Kiniksa Pharmaceuticals Ltd. (KNSA) NASDAQ

$11.40 -0.02 (-0.18%)

Market Cap: $387M

As of 11/30/21 11:20 AM EST. Market open.

(KNSA)

Kiniksa Pharmaceuticals Ltd. (KNSA) NASDAQ

$11.40 -0.02 (-0.18%)

Market Cap: $387M

As of 11/30/21 11:20 AM EST. Market open.

Kiniksa Pharmaceuticals Ltd. is a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa's portfolio of assets, ARCALYST, mavrilimumab, vixarelimab and KPL-404, are based on strong biologic rationale or validated mechanisms, target underserved ... read more

Kiniksa Pharmaceuticals Ltd. is a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa's portfolio of assets, ARCALYST, mavrilimumab, vixarelimab and KPL-404, are based on strong biologic rationale or validated mechanisms, target underserved conditions and offer the potential for differentiation. These assets are designed to modulate immunological pathways across a spectrum of diseases. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
168
CEO Compensation (Base)
$740,469
Address
.
KEY STATS
Open
$11.40
Previous Close
$11.42
Days Range
$11.39 - $12.03
52 week range
$10.30 - $24.70
Volume
78,666
Avg. Volume (30 days)
420,956
Market Cap
$387M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
33,887,757
Open
$11.40
Previous Close
$11.42
Days Range
$11.39 - $12.03
52 week range
$10.30 - $24.70
Volume
78,666
Avg. Volume (30 days)
420,956
Market Cap
$387M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
33,887,757

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR KINIKSA PHARMACEUTICALS LTD
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Patel Sanj K Chairman & CEO Feb 08, 2021 Option Exercise $1.59 4,924 7,829 4,924 Feb 10, 2021, 07:07 PM
Patel Sanj K Chairman & CEO Feb 09, 2021 Option Exercise $1.59 20,401 32,438 20,401 Feb 10, 2021, 07:07 PM
Patel Sanj K Chairman & CEO Feb 10, 2021 Option Exercise $1.59 1,600 2,544 1,600 Feb 10, 2021, 07:07 PM
Patel Sanj K Chairman & CEO Feb 08, 2021 Sale $23.00 4,528 104,144 108,042 Feb 10, 2021, 07:07 PM
Patel Sanj K Chairman & CEO Feb 10, 2021 Sale $23.07 1,137 26,231 83,336 Feb 10, 2021, 07:07 PM
Patel Sanj K Chairman & CEO Feb 09, 2021 Sale $23.04 20,401 470,039 0 Feb 10, 2021, 07:07 PM
Patel Sanj K Chairman & CEO Feb 10, 2021 Sale $23.06 1,600 36,896 0 Feb 10, 2021, 07:07 PM
Patel Sanj K Chairman & CEO Feb 08, 2021 Sale $23.00 4,924 113,252 0 Feb 10, 2021, 07:07 PM
Patel Sanj K Chairman & CEO Feb 09, 2021 Sale $23.08 23,569 543,973 84,473 Feb 10, 2021, 07:07 PM
Beetham Thomas W. EVP & Chief Legal Officer Feb 03, 2021 Sale $22.09 2,477 54,717 297,523 Feb 05, 2021, 06:55 PM
Ragosa Mark Interim CFO Dec 31, 2020 Option Exercise $17.67 1,297 22,918 3,107 Jan 05, 2021, 05:07 PM
Rizvi Qasim Chief Commercial Officer Dec 31, 2020 Option Exercise $17.67 2,161 38,185 5,176 Jan 05, 2021, 05:07 PM
Patel Sanj K Chairman & CEO Oct 09, 2020 Option Exercise $1.59 872 1,386 872 Oct 14, 2020, 05:22 PM
Patel Sanj K Chairman & CEO Oct 12, 2020 Option Exercise $1.59 150,700 239,613 150,700 Oct 14, 2020, 05:22 PM
Patel Sanj K Chairman & CEO Oct 09, 2020 Sale $21.00 872 18,312 0 Oct 14, 2020, 05:22 PM
Patel Sanj K Chairman & CEO Oct 12, 2020 Sale $21.02 99,330 2,087,917 112,570 Oct 14, 2020, 05:22 PM
Patel Sanj K Chairman & CEO Oct 12, 2020 Sale $21.02 150,700 3,167,714 0 Oct 14, 2020, 05:22 PM
Patel Sanj K Chairman & CEO Oct 09, 2020 Sale $21.00 670 14,070 211,900 Oct 14, 2020, 05:22 PM
Beetham Thomas W. EVP & Chief Legal Officer Jul 01, 2020 Sale $25.37 29,589 750,678 2,855 Jul 02, 2020, 04:13 PM
Beetham Thomas W. EVP & Chief Legal Officer Jun 10, 2020 Option Exercise $1.59 13,752 21,866 43,341 Jun 12, 2020, 05:50 PM
Beetham Thomas W. EVP & Chief Legal Officer Jun 10, 2020 Sale $25.07 13,752 344,763 29,589 Jun 12, 2020, 05:50 PM
Beetham Thomas W. EVP & Chief Legal Officer Apr 21, 2020 Sale $19.89 2,518 50,092 30,544 Apr 22, 2020, 05:39 PM
Beetham Thomas W. EVP & Chief Legal Officer Apr 20, 2020 Sale $19.06 47,423 903,882 32,107 Apr 22, 2020, 05:39 PM
Patel Sanj K Chairman & CEO Mar 06, 2020 Sale $20.00 33,115 662,300 212,570 Mar 10, 2020, 05:33 PM
Paolini John F. SVP & Chief Medical Officer Feb 27, 2020 Option Exercise $1.86 12,000 22,320 30,000 Mar 02, 2020, 05:48 PM
Paolini John F. SVP & Chief Medical Officer Feb 19, 2020 Option Exercise $3.80 22,477 85,413 40,477 Feb 21, 2020, 04:57 PM
Paolini John F. SVP & Chief Medical Officer Feb 20, 2020 Option Exercise $3.80 9,803 37,251 27,803 Feb 21, 2020, 04:57 PM
Paolini John F. SVP & Chief Medical Officer Feb 20, 2020 Sale $18.96 9,803 185,832 19,116 Feb 21, 2020, 04:57 PM
Paolini John F. SVP & Chief Medical Officer Feb 19, 2020 Sale $18.27 22,477 410,655 18,000 Feb 21, 2020, 04:57 PM
Beetham Thomas W. EVP & Chief Legal Officer Feb 14, 2020 Sale $18.58 59 1,096 79,530 Feb 19, 2020, 05:24 PM
Paolini John F. SVP & Chief Medical Officer Feb 13, 2020 Option Exercise $3.80 10,277 39,053 28,277 Feb 18, 2020, 06:05 PM
Paolini John F. SVP & Chief Medical Officer Feb 14, 2020 Option Exercise $3.80 1,039 3,948 19,039 Feb 18, 2020, 06:05 PM
Paolini John F. SVP & Chief Medical Officer Feb 13, 2020 Sale $18.29 10,277 187,966 18,000 Feb 18, 2020, 06:05 PM
Paolini John F. SVP & Chief Medical Officer Feb 14, 2020 Sale $18.33 1,039 19,045 18,000 Feb 18, 2020, 06:05 PM
Paolini John F. SVP & Chief Medical Officer Dec 05, 2019 Option Exercise $1.86 8,000 14,880 8,000 Dec 09, 2019, 05:57 PM
Paolini John F. SVP & Chief Medical Officer Oct 07, 2019 Option Exercise $1.86 10,000 18,600 10,000 Oct 09, 2019, 04:15 PM
Flynn James E 10% Owner May 29, 2018 Buy $18.97 843,352 15,996,834 843,352 May 31, 2018, 04:19 PM
Cormorant Asset Management, LP 10% Owner May 29, 2018 Buy $18.00 69,444 1,249,992 900,443 May 31, 2018, 04:13 PM
BAKER BROS. ADVISORS LP Director May 29, 2018 Buy $18.00 3,000,000 54,000,000 2,700,597 May 31, 2018, 04:10 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Patel Sanj K Chairman & CEO 02/08/2021 7,829
Patel Sanj K Chairman & CEO 02/09/2021 32,438
Patel Sanj K Chairman & CEO 02/10/2021 2,544
Patel Sanj K Chairman & CEO 02/08/2021 104,144
Patel Sanj K Chairman & CEO 02/10/2021 26,231
Patel Sanj K Chairman & CEO 02/09/2021 470,039
Patel Sanj K Chairman & CEO 02/10/2021 36,896
Patel Sanj K Chairman & CEO 02/08/2021 113,252
Patel Sanj K Chairman & CEO 02/09/2021 543,973
Beetham Thomas W. EVP & Chief Legal Officer 02/03/2021 54,717
Ragosa Mark Interim CFO 12/31/2020 22,918
Rizvi Qasim Chief Commercial Officer 12/31/2020 38,185
Patel Sanj K Chairman & CEO 10/09/2020 1,386
Patel Sanj K Chairman & CEO 10/12/2020 239,613
Patel Sanj K Chairman & CEO 10/09/2020 18,312
Patel Sanj K Chairman & CEO 10/12/2020 2,087,917
Patel Sanj K Chairman & CEO 10/12/2020 3,167,714
Patel Sanj K Chairman & CEO 10/09/2020 14,070
Beetham Thomas W. EVP & Chief Legal Officer 07/01/2020 750,678
Beetham Thomas W. EVP & Chief Legal Officer 06/10/2020 21,866
Beetham Thomas W. EVP & Chief Legal Officer 06/10/2020 344,763
Beetham Thomas W. EVP & Chief Legal Officer 04/21/2020 50,092
Beetham Thomas W. EVP & Chief Legal Officer 04/20/2020 903,882
Patel Sanj K Chairman & CEO 03/06/2020 662,300
Paolini John F. SVP & Chief Medical Officer 02/27/2020 22,320
Paolini John F. SVP & Chief Medical Officer 02/19/2020 85,413
Paolini John F. SVP & Chief Medical Officer 02/20/2020 37,251
Paolini John F. SVP & Chief Medical Officer 02/20/2020 185,832
Paolini John F. SVP & Chief Medical Officer 02/19/2020 410,655
Beetham Thomas W. EVP & Chief Legal Officer 02/14/2020 1,096
Paolini John F. SVP & Chief Medical Officer 02/13/2020 39,053
Paolini John F. SVP & Chief Medical Officer 02/14/2020 3,948
Paolini John F. SVP & Chief Medical Officer 02/13/2020 187,966
Paolini John F. SVP & Chief Medical Officer 02/14/2020 19,045
Paolini John F. SVP & Chief Medical Officer 12/05/2019 14,880
Paolini John F. SVP & Chief Medical Officer 10/07/2019 18,600
Flynn James E 10% Owner 05/29/2018 15,996,834
Cormorant Asset Management, LP 10% Owner 05/29/2018 1,249,992
BAKER BROS. ADVISORS LP Director 05/29/2018 54,000,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2021
03/31/2021
0.26%
2Q
09/30/2021
12/31/2020
10.67%
3Q
09/30/2021
06/30/2020
20.89%
5Q
09/30/2021
03/31/2020
23.72%
6Q
09/30/2021
12/31/2019
26.63%
7Q
09/30/2021
06/30/2019
28.59%
9Q
09/30/2021
03/31/2019
32.24%
10Q
Load More

Period of Report: 09/30/2021

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
03/31/2021
0.26%
2Q
12/31/2020
10.67%
3Q
06/30/2020
20.89%
5Q
03/31/2020
23.72%
6Q
12/31/2019
26.63%
7Q
06/30/2019
28.59%
9Q
03/31/2019
32.24%
10Q
Load More